Geleijns K - Search Results

1

Effect of glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.

Dekker MJ, van den Akker EL, Koper JW, Manenschijn L, Geleijns K, Ruts L, van Rijs W, Tio-Gillen AP, van Doorn PA, Lamberts SW, Jacobs BC. Dekker MJ, et al. Among authors: geleijns k. J Peripher Nerv Syst. 2009 Jun;14(2):75-83. doi: 10.1111/j.1529-8027.2009.00216.x. J Peripher Nerv Syst. 2009. PMID: 19691529

2

The occurrence of Guillain-Barre syndrome within families.

Geleijns K, Brouwer BA, Jacobs BC, Houwing-Duistermaat JJ, van Duijn CM, van Doorn PA. Geleijns K, et al. Neurology. 2004 Nov 9;63(9):1747-50. doi: 10.1212/01.wnl.0000143055.09646.31. Neurology. 2004. PMID: 15534275

3

HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.

Geleijns K, Schreuder GM, Jacobs BC, Sintnicolaas K, van Koningsveld R, Meulstee J, Laman JD, van Doorn PA. Geleijns K, et al. Neurology. 2005 Jan 11;64(1):44-9. doi: 10.1212/01.WNL.0000148727.02732.01. Neurology. 2005. PMID: 15642902

4

Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.

Geleijns K, Jacobs BC, Van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA. Geleijns K, et al. J Neuroimmunol. 2004 May;150(1-2):132-8. doi: 10.1016/j.jneuroim.2004.01.003. J Neuroimmunol. 2004. PMID: 15081257

5

Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.

Geleijns K, Laman JD, van Rijs W, Tio-Gillen AP, Hintzen RQ, van Doorn PA, Jacobs BC. Geleijns K, et al. J Neuroimmunol. 2005 Apr;161(1-2):183-9. doi: 10.1016/j.jneuroim.2004.12.001. J Neuroimmunol. 2005. PMID: 15748958

6

Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome.

Geleijns K, Roos A, Houwing-Duistermaat JJ, van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA, Jacobs BC. Geleijns K, et al. J Immunol. 2006 Sep 15;177(6):4211-7. doi: 10.4049/jimmunol.177.6.4211. J Immunol. 2006. PMID: 16951387

7

Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome.

Geleijns K, Emonts M, Laman JD, van Rijs W, van Doorn PA, Hermans PW, Jacobs BC. Geleijns K, et al. J Neuroimmunol. 2007 Oct;190(1-2):127-30. doi: 10.1016/j.jneuroim.2007.07.008. Epub 2007 Aug 30. J Neuroimmunol. 2007. PMID: 17761309

8

Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.

Jacobs BC, Koga M, van Rijs W, Geleijns K, van Doorn PA, Willison HJ, Yuki N. Jacobs BC, et al. Among authors: geleijns k. J Neuroimmunol. 2008 Feb;194(1-2):181-90. doi: 10.1016/j.jneuroim.2007.11.017. Epub 2008 Feb 21. J Neuroimmunol. 2008. PMID: 18178257

9

Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms.

Kuijf ML, Geleijns K, Ennaji N, van Rijs W, van Doorn PA, Jacobs BC. Kuijf ML, et al. Among authors: geleijns k. J Neuroimmunol. 2008 Dec 15;205(1-2):110-2. doi: 10.1016/j.jneuroim.2008.08.013. Epub 2008 Oct 5. J Neuroimmunol. 2008. PMID: 18838176

10

Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome.

Huizinga R, van den Berg B, van Rijs W, Tio-Gillen AP, Fokkink WJ, Bakker-Jonges LE, Geleijns K, Samsom JN, van Doorn PA, Laman JD, Jacobs BC. Huizinga R, et al. Among authors: geleijns k. Ann Neurol. 2015 Sep;78(3):343-54. doi: 10.1002/ana.24442. Epub 2015 Jun 30. Ann Neurol. 2015. PMID: 26017721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters